French medical device firm EOS imaging has announced plans to launch its musculoskeletal imaging system, EOSedge, at RSNA Annual Meeting in Chicago, starting on 1 December.

The company has already received regulatory approvals to launch the product in Europe, Canada and Australia. However, it is yet to be approved by the US Food and Drug Administration (FDA).

EOSedge combines X-ray detection, low-dose radiation and high image resolution to deliver enhanced musculoskeletal imaging exams.

The product features Flex Dose technology to provide an optimised dose modulation and high image resolution photon-counting detection during musculoskeletal radiography.

The combination of optimised dose modulation and high image resolution will deliver optimal image quality in musculoskeletal imaging, the company claims.

The system also features an open cabin with a motorised patient platform, which facilitates access and positioning for patients.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

EOS imaging CEO Mike Lobinsky said: “We engineered EOSedge to equip both radiologists and orthopaedic surgeons with a best-in-class imaging system that combines the latest innovations to provide high-quality diagnostic capabilities of orthopaedic conditions at a low dose.

“Images and data obtained with EOSedge will further fuel our Advanced Orthopedic Solutions while addressing a broad range of imaging and orthopaedic surgery challenges. This breakthrough in orthopaedic imaging is the result of a multi-year development effort by our outstanding inter-disciplinary team.

“Unveiling EOSedge at RSNA, the largest global imaging convention, will mark another pivotal step in realising our strategic vision to deliver the best end-to-end solutions in orthopaedic care.”

Imagerie Médicale du Parc musculoskeletal radiologist Olivier Fantino said: “EOSedge is a leap forward in image quality, both in terms of spatial resolution and image contrast, all with a low radiation dose.

“Our months of utilisation in routine have also proven enhanced patient comfort, facilitated system operation and a strong reduction of exam time. We are thrilled with our experience of EOSedge and expect it to open up new fields of application use in musculoskeletal imaging.”